Additionally, Zhou et al assessed the expression of IL-10 in primary ovarian carcinoma, and observed that the tissue level of this cytokine was significantly higher in ovarian cancer compared with benign and normal controls (15). This evidence concerns the gene IL10 and ovarian carcinoma.